In addition, CASP3 is involved in the programmed cell death of platelets and white blood cells, which leads to thrombotic events and leukopenia, respectively, in COVID-19 patients with chronic illness (61, 70, 71). Here, CASP3 is linked to Decreased total leukocyte count.